FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Explore practical smart money moves that can elevate your financial situation in everyday life. Start making informed choices now.
7,101 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Solana ETFs have drawn substantial institutional money despite a steep SOL price decline, signaling a shift in convic...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
When big deals fall apart, investors face a new reality. This guide breaks down Netflix after deal collapse, spells o...
The Federal Reserve approved Kraken for a master account, triggering a wave of concern from bank groups about regulat...
Tariff refund delays could threaten cash flow for thousands of importers, with a Cato Institute estimate placing the ...
BlackRock’s DYNF uses active factor rotation to chase leadership across value, quality, momentum, and more. As market...
A rise in 401(K) hardship withdrawals is drawing attention, but experts say it reflects liquidity needs rather than a...
Solana’s SOL is hovering near a key $95 zone as traders watch for a breakout. Fresh data show rising volumes and a ti...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
Paris Hilton unveils a fundraising drive to aid women-owned small businesses hit by disasters, expanding her philanth...